Stockreport

Oppenheimer Questions $14.5B Penumbra Deal Valuation Despite Boston Scientific's (BSX) Mew Market Dominance [Yahoo! Finance]

Boston Scientific Corporation  (BSX) 
Last boston scientific corporation earnings: 4/29 06:30 am Check Earnings Report
US:NYSE Investor Relations: investors.bostonscientific.com
PDF target on Boston Scientific to $100 from $125 with an Outperform rating. Oppenheimer is cautious on the financial optics of Boston Scientific's $14.5 billion acquisition [Read more]